Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study
- Irfan Cicin
- , Elizabeth R. Plimack
- , Howard Gurney
- , Raya Leibowitz
- , Boris Y. Alekseev
- , Francis X. Parnis
- , Avivit Peer
- , Andrea Necchi
- , Joaquim Bellmunt
- , Hiroyuki Nishiyama
- , Jason Clark
- , Mihaela Munteanu
- , Ritesh Kataria
- , Calvin Jia
- , Thomas Powles
- , Cora N. Sternberg
- Trakya University
- Macquarie University
- Sheba Medical Center at Tel Hashomer
- Tel Aviv University
- Russian Ministry of Health
- University of Adelaide
- Rambam Health Care Campus
- Fondazione IRCCS Istituto Nazionale dei Tumori
- Harvard University
- University of Tsukuba
- Incyte
- Merck & Co.
- Queen Mary University of London
- Cornell University
Research output: Contribution to journal › Article › peer-review
14
Scopus
citations